Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of JZP-110 for excessive sleepiness in adults with narcolepsy
2014-005487-15Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of solriamfetol in narcolepsy (4 arms), sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Efficacy endpoints. Started Apr 2015; status: completed.
02
Drugs
solriamfetol
03
Conditions
narcolepsy
Beyond the preview
Go deeper on 2014-005487-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005487-15.